CVS Breakup Won’t Satisfy Washington. It Could Still Work for Wall Street.
Spinning off its drugstores won’t quiet CVS’s critics, but it could leave shareholders with a more valuable company.
We haven't written up this one. WSJ Markets has the full story — the link below goes straight to it.